Proto-oncogenes regulate cell growth; mutations convert them to oncogenes, leading to cancer by disrupting normal cell ...

The findings, published in Nature Immunology, indicate that tumors edit the activity of multiple genes to avoid immune ...

A University of Alberta research team has found a potential new treatment target for ovarian cancer. Their new research is ...

The proto-oncogene (top) is depicted as a regulatory sequence (RS) followed by the coding region (gene). In the first example, a star indicates the location of the nucleotide substitution on the ...

Scientists have long known that cancer cells alter lipid metabolism, but it was generally assumed that cancer cells were ...

Scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson's to cancer and have long been thought to be 'undruggable ...

Drugs for the K-Ras oncogene inspire an approach for targeting the GTPases, a family of enzymes whose dysfunction can lead to Parkinson's and many other diseases.

Researchers found that sphingolipids, rather than serving solely as energy sources, are critical for cancer cells to evade ...

Many tumors rely on a mutation of the RAS oncogene in order to develop. Scientists hope that new anti-oncogenic drugs designed to inhibit the growth-inducing signals produced by the RAS oncogene ...

A fireside chat session is scheduled for Wednesday, September 18, 2024, in New York, NY, at 10:20 a.m. ET. A live and archived webcast of the session will be accessible under “Events & Presentations” ...

New study demonstrates that one type of lipid is so critical for immune evasion that certain cancers cannot proliferate without them. Modulating intake of dietary lipids could open up an avenue for ...